Quanterix Corp (QTRX)

NASD · Healthcare · Medical Devices · USA

Quanterix Corp is a micro cap company (market value under $300 million) in the Medical Devices industry.

Quanterix Corp develops instruments and reagents for detecting protein biomarkers at extremely low concentrations using its Simoa technology and spatial biology platforms. The company sells its products and provides laboratory testing services to research institutions, pharmaceutical companies, contract research organizations, and academic centers worldwide.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Quanterix Corp stock.

Our verdict on QTRX

Slightly undervalued: intrinsic value $3.44 per share, market price $2.86, margin of safety 16.9% (as of 2026-11-17).

A 0.8x revenue multiple, discounted for its losses, values the shares at $3.44; the price of $2.86 is 17% below that value.

ETFs with the most weight in QTRX

17 more funds hold it; the full list is part of the paid plan.

More on QTRX

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than QTRX in Medical Devices

9 more in this industry show a wider margin of safety.

Is QTRX undervalued or overvalued?

QTRX is slightly undervalued (as of the 2026-11-17 close). A 0.8x revenue multiple, discounted for its losses, values the shares at $3.44; the price of $2.86 is 17% below that value.

What is the intrinsic value of QTRX?

$3.44 per share (as of the 2026-11-17 close), against a market price of $2.86. That is a margin of safety of 16.9%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.